186 related articles for article (PubMed ID: 23698606)
1. Progress toward elimination of onchocerciasis in the Americas - 1993-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(20):405-8. PubMed ID: 23698606
[TBL] [Abstract][Full Text] [Related]
2. The Onchocerciasis Elimination Program for the Americas (OEPA).
Sauerbrey M
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
[TBL] [Abstract][Full Text] [Related]
3. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
4. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
5. The Onchocerciasis Elimination Program for the Americas: a history of partnership.
Blanks J; Richards F; Beltrán F; Collins R; Alvarez E; Zea Flores G; Bauler B; Cedillos R; Heisler M; Brandling-Bennett D; Baldwin W; Bayona M; Klein R; Jacox M
Rev Panam Salud Publica; 1998 Jun; 3(6):367-74. PubMed ID: 9734217
[TBL] [Abstract][Full Text] [Related]
6. Report from the 2009 Inter-American Conference on Onchocerciasis: progress towards eliminating river blindness in the Region of the Americas.
Wkly Epidemiol Rec; 2010 Aug; 85(33):321-6. PubMed ID: 20707042
[No Abstract] [Full Text] [Related]
7. InterAmerican Conference on Onchocerciasis, 2010: progress towards eliminating river blindness in the WHO Region of the Americas.
Wkly Epidemiol Rec; 2011 Sep; 86(38):417-23. PubMed ID: 21969940
[No Abstract] [Full Text] [Related]
8. Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November 2008.
Wkly Epidemiol Rec; 2009 Sep; 84(38):385-9. PubMed ID: 19764129
[No Abstract] [Full Text] [Related]
9. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
10. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela.
Wkly Epidemiol Rec; 2006 Jul; 81(30):293-6. PubMed ID: 16874924
[No Abstract] [Full Text] [Related]
11. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
12. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
Berger IB; Nnadozie J
J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
[TBL] [Abstract][Full Text] [Related]
13. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
14. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
15. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
16. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
17. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
18. The Carter Center's assistance to river blindness control programs: establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents.
Richards FO; Miri ES; Katabarwa M; Eyamba A; Sauerbrey M; Zea-Flores G; Korve K; Mathai W; Homeida MA; Mueller I; Hilyer E; Hopkins DR
Am J Trop Med Hyg; 2001 Aug; 65(2):108-14. PubMed ID: 11508383
[TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis (river blindness). Report from the sixteenth InterAmerican Conference on Onchocerciasis, Antigua Guatemala, Guatemala.
Wkly Epidemiol Rec; 2007 Aug; 82(35):314-6. PubMed ID: 17763565
[No Abstract] [Full Text] [Related]
20. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
